ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial

Shen, Yuanming; Kong, Beihua; Xia, Bairong; Wang, Fei; Yin, Rutie; Li, Qingshui; Yue, Ying; Kang, Shan; He, Liping; Wang, Ke; Meng, Yuanguang; Wang, Shixuan; Qu, Pengpeng; Huang, Xianghua; Guo, Ruixia; Yan, Ping; Pan, Mei; Lou, Ge; Cheng, Wenjun; Xie, Xing华中科技大学; 吉林大学; 山东大学; 哈尔滨医科大学; 河北医科大学; 四川大学; 浙江大学; 郑州大学; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-6-1
8阅读
引用收藏
分享
相关
加载中…
  • Safety and efficacy of mitoxantrone hydrochloride liposome in patients with platinum-refractory or platinum-resistant ovarian cancer: A prospective, multicenter, open-label, single-arm, phase Ib clinical trial.
    Huang, Yu; Li, Rong; Li Guiling; Luo, Yanlin; Yang, Zhijun; Lou, Ge; Ouyang, Weiwei; Xie, Rong; Luo, Wuxia; Chen, Lixin; Zhou, QiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
  • Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
    Li, Ning; Zhu, Jianqing; Yin, Rutie; Wang, Jing; Pan, Lingya; Kong, Beihua; Zheng, Hong; Liu, Jihong; Wu, Xiaohua; Wang, Li; Huang, Yi; Wang, Ke; Zou, Dongling; Zhao, Hongqin; Wang, Chunyan; Lu, Weiguo; Lin, An; Lou, Ge; Li, Guiling; Qu, Pengpeng; Yang, Hongying; Zhen, Xiaoa; Hang, Wenzhao; Hou, Jianmei; Banerjee, Ashish; Wu, Lingying
  • Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
    Li, Ning; Zhu, Jianqing; Yin, Rutie; Wang, Jing; Pan, Lingya; Kong, Beihua; Zheng, Hong; Liu, Jihong; Wu, Xiaohua; Wang, Li; Huang, Yi; Wang, Ke; Zou, Dongling; Zhao, Hongqin; Wang, Chunyan; Lu, Weiguo; Lin, An; Lou, Ge; Li, Guiling; Qu, Pengpeng; Yang, Hongying; Zhen, Xiaoa; Hang, Wenzhao; Hou, Jianmei; Wu, Lingying被引 21
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-06-02 至 2023-06-06
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-06-01
资助标注
CSPC Ouyi Pharmaceutical Group Co., Ltd
收录
ISTP · SCIE

作者

  • S

    Shen, Yuanming (第一作者)

  • K

    Kong, Beihua

查看全部 20 位作者收起作者
  • X

    Xia, Bairong

  • W

    Wang, Fei

  • Y

    Yin, Rutie

  • L

    Li, Qingshui

  • Y

    Yue, Ying

  • K

    Kang, Shan

  • H

    He, Liping

  • W

    Wang, Ke

  • M

    Meng, Yuanguang

  • W

    Wang, Shixuan

  • Q

    Qu, Pengpeng

  • H

    Huang, Xianghua

  • G

    Guo, Ruixia

  • Y

    Yan, Ping

  • P

    Pan, Mei

  • L

    Lou, Ge

  • C

    Cheng, Wenjun

  • X

    Xie, Xing

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417